基于定性比较分析的政府新药政策分析-analysis of governments new drug policy based on qualitative comparative analysis.docxVIP

  • 5
  • 0
  • 约5.52万字
  • 约 73页
  • 2018-05-18 发布于上海
  • 举报

基于定性比较分析的政府新药政策分析-analysis of governments new drug policy based on qualitative comparative analysis.docx

基于定性比较分析的政府新药政策分析-analysis of governments new drug policy based on qualitative comparative analysis

AbstractThetotalsizeofChinaspharmaceuticalmarketisthethirdlargestinthe world, however,thepharmaceuticalinnovationabilityisfarbehindother pharmaceuticalpowerevenIndia.Inordertoenhancedruginnovationcapability inchina,weneedtocarry outaseriesofnewdrug policyinnovationinthenew drugresearchanddevelopment,registeredandlistedthreestages,forcreatinga policyenvironment conducive forthenewdrugsresearch.Based onclarifyingthecharacteristicsofeachstageofmedicalmarketand druginnovationactivities,thisarticlehasthemaingovernmentdrugpolicy factorsofwhichhaveincentiveandguaranteeeffectondruginnovation. Secondly,30countrieswhosedrug policyinnovationareclassicwerechosenas the casesofthisarticle,QCAisoftenusedtofind outhowthedrug policy andits combination ofthefactorsinfluencethedruginnovation ofacountry.According totheresultofQCA,analyzethecharacteristicandincentiveeffectofvarious drugpolicies.Thenfindoutthetypeofgovernmentpolicywhichfitwiththe situationofourcountryandpropoundthesuggestions.Whichcomesto conclusionisthat,strictregistrationwithstrongdegreeofpatentprotectionand druginnovation isthenecessarycondition forenhancingdruginnovationability.Theconclusionsofthispaperincludethat,firstly,thestrictexaminationand approvalstrongdegreepatentprotectionarenecessaryconditionforenhancing druginnovation ability.Secondly,thetypeofinvestmentpolicyand pricingpolicy hasnopositiverelationshipwithacountrys drug innovationability.Intheprocess whenwe choosethetypeofinvestmentpolicyand pricingpolicy weshouldled by thegovernmentleadingmodetotheenterpriseleadingmode.Eventually, this paperdeterminedthegovernmentspublicinvestmentpolicyfactors,registration andapprovalpolicy,drugpricingpolicyandpatentprotectionpolicyasthefour druginnovationpolicyimplicationswhichinfluencepharmaceuticalinnovation activities.Keywords: Drugpolicy; Druginnovation; QCA目录摘要................................................................................................................................IAbstract.....................

您可能关注的文档

文档评论(0)

1亿VIP精品文档

相关文档